Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes

Immunobiology

Volumn 218, Issue 11, 2013, Pages 1392-1401

  Pfeiffer, Isabell A ^a   Zinser, Elisabeth ^a   Strasser, Erwin ^a   Stein, Marcello F ^a   Dörrie, Jan ^a   Schaft, Niels ^a   Steinkasserer, Alexander ^a   Knippertz, Ilka ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

B cell; Leukoreduction system chamber; Monocyte derived dendritic cell; Peripheral blood mononuclear cell; T cell

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; BLOOD BUFFY COAT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL MIGRATION; CELL SELECTION; COCULTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTOPHERESIS;

ANTIGEN PRESENTING CELL; APC; B CELL; CBA; CTL; CYTOMETRIC BEAD ARRAY; CYTOTOXIC T CELL; DC; DENDRITIC CELL; ELECTROPORATION; EP; GFP; GM-CSF; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; IDC; IFN; IL; IMMATURE DENDRITIC CELL; INTERFERON; INTERLEUKIN; LEUKOREDUCTION SYSTEM CHAMBER; LIPOPOLYSACCHARIDE; LPS; LRSC; MAJOR HISTOCOMPATIBILITY COMPLEX; MATURATION COCKTAIL; MATURE DENDRITIC CELL; MC; MDC; MHC; MIXED LYMPHOCYTE REACTION; MLR; MODC; MONOCYTE-DERIVED DENDRITIC CELL; NAF; NATURAL KILLER CELL; NK CELL; NON-ADHERENT FRACTION; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELL; PGE(2); PI; PLATELET; PLT; PROPIDIUM IODIDE; PROSTAGLANDIN E(2); SEM; STANDARD ERROR OF THE MEAN; T CELL; T CELL RECEPTOR; TCR; TNF; TUMOR NECROSIS FACTOR; VOL; VOLUME; WBC; WHITE BLOOD CELL;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CRYOPRESERVATION; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PLATELETPHERESIS;

EID: 84884125559     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.07.005     Document Type: Article

References (34)

1. Adema G.J., de Vries I.J., Punt C.J., Figdor C.G. Migration of dendritic cell based cancer vaccines: in vivo veritas?. Curr. Opin. Immunol. 2005, 17:170-174.
2. Banchereau J., Pascual V., O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat. Immunol. 2012, 13:925-931.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Berger T.G., Feuerstein B., Strasser E., Hirsch U., Schreiner D., Schuler G., Schuler-Thurner B. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J. Immunol. Methods 2002, 268:131-140.
5. Berger T.G., Strasser E., Smith R., Carste C., Schuler-Thurner B., Kaempgen E., Schuler G. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J. Immunol. Methods 2005, 298:61-72.
6. Birkholz K., Hofmann C., Hoyer S., Schulz B., Harrer T., Kampgen E., Schuler G., Dorrie J., Schaft N. A fast and robust method to clone and functionally validate T-cell receptors. J. Immunol. Methods 2009, 346:45-54.
7. Dietz A.B., Bulur P.A., Emery R.L., Winters J.L., Epps D.E., Zubair A.C., Vuk-Pavlovic S. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion (Paris) 2006, 46:2083-2089.
8. Dorrie J., Schaft N., Muller I., Wellner V., Schunder T., Hanig J., Oostingh G.J., Schon M.P., Robert C., Kampgen E., Schuler G. Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes. Cancer Immunol. Immunother. 2008, 57:467-477.
9. Dresch C., Leverrier Y., Marvel J., Shortman K. Development of antigen cross-presentation capacity in dendritic cells. Trends Immunol. 2012, 33:381-388.
10. Ebner S., Neyer S., Hofer S., Nussbaumer W., Romani N., Heufler C. Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats. J. Immunol. Methods 2001, 252:93-104.
11. Erdmann M., Dorrie J., Schaft N., Strasser E., Hendelmeier M., Kampgen E., Schuler G., Schuler-Thurner B. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J. Immunother. 2007, 30:663-674.
12. Feuerstein B., Berger T.G., Maczek C., Roder C., Schreiner D., Hirsch U., Haendle I., Leisgang W., Glaser A., Kuss O., Diepgen T.L., Schuler G., Schuler-Thurner B. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J. Immunol. Methods 2000, 245:15-29.
13. Gunn M.D. Chemokine mediated control of dendritic cell migration and function. Semin. Immunol. 2003, 15:271-276.
14. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012, 12:557-569.
15. Knippertz I., Hesse A., Schunder T., Kampgen E., Brenner M.K., Schuler G., Steinkasserer A., Nettelbeck D.M. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. J. Immunother. 2009, 32:524-538.
16. Knippertz I., Stein M., Dörrie J., Schaft N., Müller I., Deinzer A., Steinkasserer A., Nettelbeck D.M. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int. J. Hyperthermia 2011, 27:591-603.
17. Kotzor N., Lechmann M., Zinser E., Steinkasserer A. The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells. Immunobiology 2004, 209:129-140.
18. Kurts C., Robinson B.W., Knolle P.A. Cross-priming in health and disease. Nat. Rev. Immunol. 2010, 10:403-414.
19. Mucci I., Legitimo A., Compagnino M., Consolini R., Migliaccio P., Metelli M.R., Scatena F. The methodological approach for the generation of human dendritic cells from monocytes affects the maturation state of the resultant dendritic cells. Biologicals 2009, 37:288-296.
20. Neron S., Thibault L., Dussault N., Cote G., Ducas E., Pineault N., Roy A. Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells. Transfusion (Paris) 2007, 47:1042-1049.
21. Prechtel A.T., Turza N.M., Kobelt D.J., Eisemann J.I., Coffin R.S., McGrath Y., Hacker C., Ju X., Zenke M., Steinkasserer A. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 2005, 86:1645-1657.
22. Ringwald J., Zingsem J., Zimmermann R., Strasser E., Antoon M., Eckstein R. First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors. Vox Sang. 2003, 85:267-275.
23. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
24. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
25. Scandella E., Men Y., Legler D.F., Gillessen S., Prikler L., Ludewig B., Groettrup M. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004, 103:1595-1601.
26. Schaft N., Dorrie J., Thumann P., Beck V.E., Muller I., Schultz E.S., Kampgen E., Dieckmann D., Schuler G. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 2005, 174:3087-3097.
27. Schuler G. Dendritic cells: indispensable?. Cancer J. 2011, 17:337-342.
28. Stein M.F., Lang S., Winkler T.H., Deinzer A., Erber S., Nettelbeck D.M., Naschberger E., Jochmann R., Sturzl M., Slany R.K., Werner T., Steinkasserer A., Knippertz I. Multiple IRF- and NFkB-sites cooperate in mediating cell type- and maturation-specific activation of the human CD83 promoter in dendritic cells. Mol. Cell. Biol. 2013, 33:1331-1344.
29. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271-296.
30. Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 2012, 30:1-22.
31. Strasser E.F., Weidinger T., Zimmermann R., Ringwald J., Eckstein R. Recovery of white blood cells and platelets from leukoreduction system chambers of Trima Accel and COBE Spectra plateletpheresis devices. Transfusion (Paris) 2007, 47:1943-1944.
32. Thurner B., Roder C., Dieckmann D., Heuer M., Kruse M., Glaser A., Keikavoussi P., Kampgen E., Bender A., Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Methods 1999, 223:1-15.
33. Tiscornia I., Sanchez-Martins V., Hernandez A., Bollati-Fogolin M. Human monocyte-derived dendritic cells from leukoreduction system chambers after plateletpheresis are functional in an in vitro co-culture assay with intestinal epithelial cells. J. Immunol. Methods 2012, 384:164-170.
34. Weidinger T.M., Keller A.K., Weiss D., Zimmermann R., Eckstein R., Strasser E.F. Peripheral blood mononuclear cells obtained from leukoreduction system chambers show better viability than those from leukapheresis. Transfusion (Paris) 2011, 51:2047-2049.